Literature DB >> 1306075

The effect of dilution, pH and ionic strength of plasma on t-PA precipitation in euglobulin fraction.

S Y Hong1, H K Shin, D H Yang.   

Abstract

In order to evaluate the influence of dilution, pH and ionic strength on the precipitation of t-PA and PAI-1 during euglobulin precipitation, we measured t-PA Ag, PAI-1 Ag and fibrinolytic activity in the euglobulin fraction made of pooled plasma from liver cirrhosis patients, under various conditions by changing pH, ionic strength and degree of dilution. The precipitation of t-PA Ag in the euglobulin fraction was enhanced by decreasing the ionic strength and greatest at pH 6.0. The fibrinolytic activity in the euglobulin fraction showed consistent changes with t-PA Ag under varying pH and ionic strength. The precipitation of t-PA Ag was not influenced by the dilution factor but the larger the dilution factor, the greater the PAI-1 and the smaller the fibrinolytic activity in the euglobulin fraction. PAI Ag in euglobulin fraction showed consistent changes with t-PA Ag in the euglobulin fraction regardless of the changes in ionic strength and pH. The amount of precipitation of t-PA and PAI-1 was increased by the presence of dextran sulfate, under varying pH, ionic strength and dilution conditions. Our results show that the currently used conditions for standard euglobulin precipitation are the most favorable for t-PA precipitation into the euglobulin fraction. The fibrinolytic activity exerted in the euglobulin fraction seems to depend on the amount of t-PA-PAI-1 complex rather than minimized protease inhibitor in the euglobulin fraction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306075      PMCID: PMC4532111          DOI: 10.3904/kjim.1992.7.2.73

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

1.  Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.

Authors:  J Hauert; G Nicoloso; W D Schleuning; F Bachmann; M Schapira
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

2.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall.

Authors:  D C Rijken; G Wijngaards; J Welbergen
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

3.  Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.

Authors:  B Wiman; J Chmielewska; M Rånby
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

4.  Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.

Authors:  J H Verheijen; G T Chang; C Kluft
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

5.  PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.

Authors:  T Urano; K Sumiyoshi; M H Pietraszek; Y Takada; A Takada
Journal:  Thromb Haemost       Date:  1991-10-01       Impact factor: 5.249

6.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

7.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

8.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

Authors:  I M Nilsson; H Ljungnér; L Tengborn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

9.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

Authors:  A Hamsten; B Wiman; U de Faire; M Blombäck
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

10.  The role of the fibrinolytic system in deep vein thrombosis.

Authors:  B Wiman; B Ljungberg; J Chmielewska; G Urdén; M Blombäck; H Johnsson
Journal:  J Lab Clin Med       Date:  1985-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.